Similarly, Min Zheng et al. reported that the podocyte-associated biomarkers podocalyxin, CD2-AP, α-actin4, and podocin were upregulated in 51 diabetic patients with DKD versus 13 controls. The gene discussed is PODXL; the disease is diabetic kidney disease.